GSK rules out HIV spinout as generics hit results
May 06, 2015 at 07:22 AM EDT
GlaxoSmithKline looks set to continue its earnings slide in 2015, as generic competition continues to hit sales of asthma treatment Advair.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.